May 2020

Column

Editor's Page

Making the Most of Data: Improving EHRs and Gleaning Insight From RWD

05/19/2020

Winston Wong, PharmD, Editor-in-Chief

Electronic health records (EHRs) can improve the ability to diagnose diseases, reduce medical errors, and improve patient outcomes. However, data collection platforms are only as good as their design and usability....

...

05/19/2020

Journal of Clinical Pathways

Pharma Insights

Real-World Data Will Continue to Provide Real Value to the Drug Development and Commercialization Process

05/19/2020

Sajjad Raza, MD, PhD, MSM

Kathy Lang, PhD

Randomized controlled trials provide critically needed evidence of drugs’ safety and efficacy, yet their results are not always generalizable to diverse populations in less idealized settings. Thus, we need data...

...

05/19/2020

Journal of Clinical Pathways

Trending From ACCC

Telehealth in the Wake of COVID-19

05/19/2020

JCP Editors

In early December 2019, the Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute hosted a Telemedicine Roundtable, convening Institute leadership and experts from relevant areas of health care....

In...

05/19/2020

Journal of Clinical Pathways

Clinical Pathways GPS

How COVID-19 Will Change the Patient Journey, Reimbursement, and Care Delivery

05/19/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Value-based care has led to much change in health care over the years, and COVID-19 is pushing change faster and even further. These changes forced by COVID-19 will have long-term effects on every aspect of care...

...

05/19/2020

Journal of Clinical Pathways

News

Conference Coverage

2020 Community Oncology Alliance Annual Conference

05/19/2020

JCP Editors

The 2020 Community Oncology Alliance (COA) Annual Conference had an educational agenda planned to benefit the nationwide workforce of community oncology professionals and allied industries. It was delivered through a...

The...

05/19/2020

Journal of Clinical Pathways

Department

Research in Review

05/19/2020

JCP Editors

CMS Hospital IPPS Proposed Rule Includes CAR-T Reimbursement Updates The Centers for Medicare & Medicaid Services has released its proposed Hospital Inpatient Prospective Payment System rule for 2021. Full...

CMS...

05/19/2020

Journal of Clinical Pathways

Tools and Resources

Tools for Transformation

Drivers and Projected Trends for Post-COVID-19 Cancer Care Operations

05/19/2020

Gordon Kuntz—Column Editor

Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...

Gordon...

05/19/2020

Journal of Clinical Pathways

Feature

Research Reports

The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis

05/19/2020

Abdalla Aly, PhD

Courtney Johnson, MPH

Yunes Doleh, MPH, PharmD

Viktor Chirikov, MS, PhD

Marc Botteman, MSc

Rahul Shenolikar, MS, PhD

Arif Hussain, MD

Abstract: Urothelial carcinoma (UC) is generally diagnosed early and may incur significant lifetime costs. This study estimated, from the payer’s perspective, the lifetime costs among patients diagnosed with UC...

...

05/19/2020

Journal of Clinical Pathways

From the Field

Enhancing the Electronic Health Record to Improve the Quality of Breast Cancer Care in Eastern North Carolina

05/19/2020

Helen M Johnson, MD

Lauren E Geisel, MD

Andrew Weil, MD

Mahvish Muzaffar, MD

Nasreen A Vohra, MD

Phyllis DeAntonio, RN

Jan H Wong, MD

Abstract: Eastern North Carolina (ENC) is home to a rural population that suffers from disparities in breast cancer outcomes. It has been demonstrated that evidence-based clinical pathways can improve quality of...

...

05/19/2020

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

May 2020

Column

News

Department

Tools and Resources

Feature

Current Issue

Special Reports

Subscribe

Volume 6

Specialties

Events

Year Round Education

HMP Global Products